These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
473 related articles for article (PubMed ID: 11470139)
1. The future of human gene therapy. Rubanyi GM Mol Aspects Med; 2001 Jun; 22(3):113-42. PubMed ID: 11470139 [TBL] [Abstract][Full Text] [Related]
2. Viral-mediated gene transfer for cancer treatment. Wilson DR Curr Pharm Biotechnol; 2002 Jun; 3(2):151-64. PubMed ID: 12022258 [TBL] [Abstract][Full Text] [Related]
6. Points to consider for ethics committees in human gene therapy trials. Dettweiler U; Simon P Bioethics; 2001 Oct; 15(5-6):491-500. PubMed ID: 12058773 [TBL] [Abstract][Full Text] [Related]
7. Gene therapy for cardiovascular diseases. Gruchala M; Roy H; Bhardwaj S; Ylä-Herttuala S Curr Pharm Des; 2004; 10(4):407-23. PubMed ID: 14965202 [TBL] [Abstract][Full Text] [Related]
9. Predicting the future of human gene therapy for cardiovascular diseases: what will the management of coronary artery disease be like in 2005 and 2010? Dzau VJ Am J Cardiol; 2003 Nov; 92(9B):32N-35N. PubMed ID: 14615024 [TBL] [Abstract][Full Text] [Related]
11. Non-viral nucleic acid delivery: key challenges and future directions. Elsabahy M; Nazarali A; Foldvari M Curr Drug Deliv; 2011 May; 8(3):235-44. PubMed ID: 21291381 [TBL] [Abstract][Full Text] [Related]
12. A realistic chance for gene therapy in the near future. Worgall S Pediatr Nephrol; 2005 Feb; 20(2):118-24. PubMed ID: 15549408 [TBL] [Abstract][Full Text] [Related]
13. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing. Ulrich-Vinther M Acta Orthop Suppl; 2007 Apr; 78(325):1-64. PubMed ID: 17427340 [TBL] [Abstract][Full Text] [Related]
14. Development and use of gene transfer for treatment of cardiovascular disease. Baker AH J Card Surg; 2002; 17(6):543-8. PubMed ID: 12643466 [TBL] [Abstract][Full Text] [Related]
15. Split vector systems for ultra-targeted gene delivery: a contrivance to achieve ethical assurance of somatic gene therapy in vivo. Tolmachov OE Med Hypotheses; 2014 Aug; 83(2):211-6. PubMed ID: 24854575 [TBL] [Abstract][Full Text] [Related]
17. Invasive drug delivery. Blömer U; Ganser A; Scherr M Adv Exp Med Biol; 2002; 513():431-51. PubMed ID: 12575831 [TBL] [Abstract][Full Text] [Related]
18. Gene therapy for atherosclerotic cardiovascular disease: a time for optimism and caution. O'Brien T; Simari RD Mayo Clin Proc; 2000 Aug; 75(8):831-4. PubMed ID: 10943238 [TBL] [Abstract][Full Text] [Related]
19. Emerging vectors and targeting methods for nonviral gene therapy. Lavigne MD; Górecki DC Expert Opin Emerg Drugs; 2006 Sep; 11(3):541-57. PubMed ID: 16939390 [TBL] [Abstract][Full Text] [Related]
20. Specific targets in tumor tissue for the delivery of therapeutic genes. Günther M; Wagner E; Ogris M Curr Med Chem Anticancer Agents; 2005 Mar; 5(2):157-71. PubMed ID: 15777223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]